Innovation Pharmaceuticals Inc (IPIX)

[iclight]

I guess negative points aren't "points of interest".

Some people owe me an apology regarding my negative comments on Kevetrin data:

From the article:

A cancer drug called Kevetrin, which just finished Phase 1 trials. Bertolino said he’s hoping to start a Phase 2a study this fall. Right now, he’s not looking for a clinical effect, only to confirm that the drug acts on a protein that plays a role in tumors known as p53. Kevetrin will eventually be tested against ovarian cancer, but the current formulation doesn’t remain effective long enough to be effective.